?價值大師評分 :
0
/100
1月
3月
6月
今年
1年
3年
5年
10年
15年
全部
3年:0%
藥明生物 內部交易概覽
最近18個月交易的高管股東 | 交易次數 | 凈買入（股） |
|---|---|---|
| Jpmorgan Chase & Co. | 15 | 93,649,591 |
| Li Ge | 3 | 7,511,500 |
| New Wuxi Life Science Holdings Limited | 0 | 0 |
| BlackRock, Inc. | 0 | 0 |
| Liu Xiaozhong | 0 | 0 |
| Citigroup Inc. | 0 | 0 |
交易分段匯總 | 買入數量 | 賣出數量 | 凈買入（股） |
|---|---|---|---|
| 最近1個月 | 0 | 0 | 0 |
| 最近3個月 | 0 | 0 | 0 |
| 最近6個月 | 0 | 0 | 0 |
| 最近12個月 | 1,445,000 | 0 | 1,445,000 |
| 最近18個月 | 151,220,108 | 46,955,867 | 104,264,241 |
| 最近36個月 | 159,318,350 | 52,569,706 | 106,748,644 |
藥明生物 內部交易
今年
1年
3年
5年
10年
15年
全部
藥明生物 最新內部交易
Li Ge | 2201 Interest of corporation controlled by you | 2024-06-24 | 買入 | 1,445,000 | 592,902,633 |
HK$11.57
|
+103.11%
|
BlackRock, Inc. | 2201 Interest of corporation controlled by you | 2024-05-21 | - | 25,845,937 | 222,384,147 |
HK$0
|
--
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-05-13 | - | 11,918,063 | 49,525,165 |
HK$0
|
--
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-05-13 | 買入 | 35,400,514 | 228,328,272 |
HK$14.4
|
+63.19%
|
BlackRock, Inc. | 2201 Interest of corporation controlled by you | 2024-05-10 | - | 1,548,511 | 213,867,876 |
HK$0
|
--
|
BlackRock, Inc. | 2201 Interest of corporation controlled by you | 2024-05-02 | - | 12,715,268 | 215,685,685 |
HK$0
|
--
|
Li Ge | 2201 Interest of corporation controlled by you | 2024-03-28 | 買入 | 831,000 | 590,257,633 |
HK$13.88
|
+69.31%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-27 | - | 335,176 | 73,508,032 |
HK$0
|
--
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-27 | 買入 | 3,406,017 | 213,733,454 |
HK$13.68
|
+71.78%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-19 | 賣出 | 18,993,879 | 249,045,875 |
HK$14
|
+67.86%
|